We sought to identify optimal temporal windows for lockdown-based mitigation strategies on infectious disease spreads. An age-structured multi-compartmental Susceptible-Infected-Recovered (SIR) model was used to estimate infection spreads under parametric variation of lockdown intensity and duration from the data of SARS-CoV2 cases in India between January to July, 2020. The resulting parameter values were used to simulate lockdown outcomes for a wide range of start times and durations. Lockdowns were simulated as intervention strategies that modified weights assigned to social contact matrices for work, school and other places. Lockdown efficacy was assessed by the maximum number of infections recorded during a simulation run. Our analysis shows that lockdown outcomes depend sensitively on the timing of imposition and that it is possible to minimize lockdown durations while limiting case loads to numbers below the hospitalization thresholds. Such timing based effects arise naturally from the non-linear nature of SIR dynamics.
We sought to simulate lockdown scenarios using an Agent Based Modelling (ABM) strategy, which is a new modelling paradigm that seeks to simulate the actions and interactions of autonomous agents within an environment. The spread of infectious viral diseases occur over a connected social network. Specifically, the goal was to understand the effect of network topology and lockdown strategies on disease spreading dynamics. To explore the effect of topology we assumed the social network over which the disease spreads to have small-world or scale-free properties characterized by a rewiring probability and degree distribution respectively. Lockdowns were simulated as intervention strategies that modified the spreading dynamics of infection over a given graph structure through changes in properties of agent interaction. Lockdown efficacy was assessed by the maximum number of infections recorded during a simulation run. Thereafter, lockdown efficacy was evaluated as a function of lockdown start times and duration. Thus, we propose that ABM approach can be used to assess various lockdown strategies that aim to prevent breakdown of medical infrastructure while accounting for realistic social network configurations specific to a local population.
Lockdowns are disease mitigation strategies that aim to contain the spread of an infection by restricting the interactions of its carriers. Lockdowns can thus have a considerable economic cost, which makes the identification of optimal lockdown windows that minimize both infection spread and economic disruption imperative. A well-known feature of complex dynamical systems is their sensitivity to the timing of external inputs. Hence, we hypothesized that the timing and duration of lockdowns should dictate lockdown outcomes. We demonstrate this concept computationally from two perspectives - Firstly, a stochastic "small-scale" Agent Based Model (ABM) of a Susceptible-Infected-Recovered (SIR) disease spread and secondly, a deterministic "large-scale" perspective using a multi-group SIR mass model with parameters determined from the SARS-CoV2 data in India. Lockdowns were implemented as an effective reduction of interaction probabilities in both models. This allowed us to evaluate the parametric variations of lockdown intensity and duration onto the dynamical properties of the infection spread over different connection topologies. We definitively show that the lockdown outcomes in both the stochastic small-scale and deterministic large-scale perspectives depend sensitively on the timing of its imposition and that it is possible to minimize lockdown duration while limiting case loads to numbers below hospitalization thresholds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.